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Abstract 20 
Osteoarthritis is a degenerative joint disease and a world-wide healthcare burden. 21 
Characterized by cartilage degradation, subchondral bone thickening and osteophyte 22 
formation, osteoarthritis inflicts much pain and suffering, for which there are currently 23 
no disease-modifying treatments available. Mouse models of osteoarthritis are proving 24 
critical in advancing our understanding of the underpinning molecular mechanisms. 25 
The STR/ort mouse is a well-recognized model which develops a natural form of 26 
osteoarthritis very similar to the human disease. In this Review we discuss the use of 27 
the STR/ort mouse in understanding this multifactorial disease with an emphasis on 28 
recent advances in its genetics and its bone, endochondral and immune phenotypes.     29 
Keywords: STR/ort; osteoarthritis; articular cartilage; subchondral bone 30 
Running headline: The STR/ort mouse OA model– an update  31 
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Introduction 41 
Animal models are a vital tool for the study of osteoarthritis (OA). In particular they provide 42 
scope to examine the early aetiological processes where equivalent human samples are 43 
difficult to obtain, and they remain necessary in developing and testing new treatments1. 44 
Animal OA models consist broadly of those requiring invasive manipulation, such as surgical 45 
joint destabilization by ligament transection or meniscectomy, those destabilizing the joint 46 
without surgical manipulation such as collagenase-induced instability, those exploiting non-47 
surgical application of mechanical trauma, or those in which OA develops naturally2-4. 48 
Surgical models are representative chiefly of trauma-induced secondary human OA, whilst 49 
natural models offer an opportunity to investigate OA without known aetiology, akin to 50 
primary OA5. All of these OA models principally use the mouse; well-used mainly due to the 51 
ease with which its genome can be manipulated and because of its robust breeding capacities, 52 
easy husbandry and price of upkeep. In addition, its relatively short life-span allows for the 53 
examination of OA progression, from initiation to late degenerative stages, to be undertaken 54 
in a compressed timescale. 55 
Numerous mouse strains develop OA with advancing age, offering proof that genetic 56 
predisposition or susceptibility is an important factor. They, nonetheless, develop OA with 57 
differing incidences6; high incidence and severity was identified in the STR/1N mouse, from 58 
which the inbred STR/ort strain is directly derived. The STR/ort mouse is a well-recognized 59 
model of spontaneous OA and, to date, has featured in over 80 studies. STR/ort mice develop 60 
OA spontaneously early in life and show many human OA characteristics, including 61 
proteoglycan (PG) loss, articular cartilage (AC) fibrillation, active extracellular matrix 62 
(ECM) degradation, osteophyte formation and subchondral sclerosis. Herein, we will revisit 63 
(see Watanbe et al., 2011 and Mason et al., 20017, 8) past and new data from STR/ort mice 64 
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with view to revealing how they inform our understanding of early aetiology, 65 
pathophysiology and potential treatment of OA.   66 
Origins of the STR/ort mouse 67 
The STR/1N strain was first isolated by Strong (1951) during an extensive selective-breeding 68 
programme designed to identify traits for resistance to tumour induction at the site of injected 69 
carcinogens9. Tandem crosses between CBA, N, J and K strains generated a new NH strain 70 
that was treated for multiple generations with the carcinogen, 20-methylcolanthrene creating 71 
the NHO strain. Further selection using another carcinogen (4-methylcholantrene) ended with 72 
a piebald mutation and serendipitous generation of the STR/1N strain7, which exhibited 73 
obesity and spontaneous OA at a young age10. After some breeding without brother-sister 74 
pairing and arrival at the Institute of Orthopaedics, Stanmore (UK), the strain was renamed 75 
STR/ort, as it is now commonly known. The CBA mouse is the only remaining parental 76 
strain available today and it’s lack of overt OA makes it effective as a control11.  77 
STR/ort mouse OA phenotype 78 
STR/ort OA susceptibility genetics are uncertain and their phenotype is better characterised. 79 
STR/ort mice develop OA in knee, ankle, elbow and temporomandibular joints12-15. The first 80 
studies by Walton described a greater incidence of OA knee pathology in male than in female 81 
STR/ort mice; a sexual dimorphism in this model which is the opposite to that in the human 82 
disease16, 17. In male mice, Walton reported steadily increasing OA incidence and severity 83 
from 18wks of age. We have shown, by toluidine blue staining followed by the 84 
internationally-recognized OARSI grading system18, that the OA in the STR/ort mouse 85 
invariably predominates on the medial tibial plateau at the cruciate ligament insertion, is 86 
followed by AC clefting/fibrillation extending centrally and then later to medial femoral 87 
condyles and is accompanied by osteophyte development and by subchondral bone sclerosis 88 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
5 
 
which, with extensive AC loss across both condyles, later becomes exposed. Chondrogenesis 89 
and ossification in collateral/cruciate ligaments, and meniscal hyperplasia, ossification and 90 
eburnation is seen in severely affected joints. This is consistent with greater chondrocyte 91 
proliferation, synovium hyperplasia and cluster formation in menisci of STR/1N mice19 92 
described as tentative evidence for reparative processes. It fails to match, however, with 93 
prominent synovial inflammatory infiltrates seen in STR/ort mice by some.  Our recent work 94 
examining whether gait changes are a meaningful measure of STR/ort OA severity showed 95 
that age-related modifications in paw area precede OA onset and may therefore be useful for 96 
longitudinal monitoring of OA development in these mice20. 97 
Only a few studies have explored OA-associated pain in this model. Increased basal and 98 
evoked prostaglandin E2 release has been observed in knee preparations from 18-week-old 99 
STR/1N mice, which may enhance nociceptor sensitivity and chronic OA pain21. However, 100 
we have found that male STR/ort mice do not exhibit any pain-associated behaviours with 101 
OA development, even when treated with the opioid antagonist naloxone20. They did 102 
however exhibit normal pain behaviours in response to complete Freund’s adjuvant-induced 103 
arthritis, suggestive that these mice are not inherently insensitive to joint pain20. Despite this, 104 
the precise nature of OA pain in STR/ort mice is unresolved. 105 
Mechanical aetiology of OA in the STR/ort mouse 106 
Several lines of evidence suggest that OA development in STR/ort mice involves a 107 
mechanical contribution. Indeed, Walton (1977) showed a close relationship between AC 108 
lesions and medial patella dislocation, medial collateral ligament calcification/ossification 109 
and lateral subluxation of the femur16 and that surgical patella fixation decreased OA, 110 
whereas patella dislocation in CBA mice induced OA22. Patella dislocation has also been 111 
linked to abnormal tibial internal torsion in STR/ort (STR/OrtCrlj) mice and to advanced age, 112 
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leading Naruse et al., (2009) to propose this as the cause of STR/ort OA23. However, Das-113 
Gupta et al., reported an incidence of patella dislocation in only 22% of STR/ort mice, 114 
reinforcing this with radiological studies showing not all mice with OA had displaced patellae, 115 
demonstrating that this cannot be a primary event24. We find that patella dislocation 116 
correlates with severe OA, but can be absent even in some STR/ort mice with severe AC 117 
degeneration (unpublished data). Other studies have indicated that this medial patellar 118 
luxation in STR/1N mice is likely due to medial tibia AC degeneration, pronounced 119 
instability and varus knee joint deformity, which contrasts with the valgus characterising 120 
knee OA in C57/Bl6 mice25, 26. Mechanical changes induced by patella dislocation could 121 
nonetheless be an important contributor and aggravator of OA development in STR/ort mice.   122 
Development of ankle OA in STR/ort mice has similarly been linked with calcaneal 123 
dislocation, with elevation progressively more pronounced in ageing mice where it eventually 124 
became parallel to the distal tibia (unpublished). The cause for this ankle deformity is 125 
unknown, but suggests a possible defect in maintaining joint stability with spontaneous 126 
subluxation and later severe disruption of navicular and tarsal bones in male STR/ort mice15. 127 
Together, these studies suggest a widespread instability phenotype that disrupts joint 128 
mechanics to promote OA. This was however deemed unlikely by scoring of multiple 129 
STR/ort mouse joints which found that patellar and calcaneal displacements rarely occurred 130 
in the same limb, suggesting they were likely independent events12.   131 
The anterior cruciate ligaments of STR/ort mice also exhibit lower ultimate strength, 132 
increased collagen metabolism and matrix metalloproteinase (MMP) activity compared to 133 
CBA mice at 20-30wks27, 28. This suggests that STR/ort mice have inherently weaker 134 
ligaments, which could facilitate patella dislocation and joint instability. Changes in 135 
ligaments and menisci in STR/ort OA joints, with chondrogenesis and ossification, are also 136 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
7 
 
seen in surgical OA models, supporting their mechanical aetiology. These changes would, in 137 
turn, modify the mechanical properties of the ligaments and cause further joint damage.  138 
We have recently explored the importance of mechanical loading in lesion induction and 139 
pathological OA progression in STR/ort mice using a non-invasive knee joint trauma 140 
model29. We found that AC in STR/ort mice is relatively resistant to mechanical trauma - it 141 
can bear greater applied loads without failure – which is associated with thicker AC at all 142 
ages relative to CBA mice29. These data suggest that STR/ort mouse OA susceptibility is 143 
unlikely due to enhanced vulnerability of AC to mechanical lesion induction. We did, 144 
however, find that repetitive mechanical loading over a two week-long period promoted 145 
progression of spontaneously-occurring AC lesions in the medial tibia, suggesting that 146 
mechanical disturbances may nevertheless accelerate OA progression in these mice29. This 147 
merges well with human studies showing that mechanical loading of joints is likely a major 148 
determinant of both OA onset and progression and further highlights the attractiveness of the 149 
STR/ort mouse as a model for exploring interplay with mechanical factors in OA 150 
development.   151 
Genetic studies in the STR/ort mouse 152 
Numerous genetic and microarray analyses have been performed in STR/ort mice. Studies by 153 
Jaeger et al (2008) confirmed Mendelian OA inheritance and concluded that its polygenicity 154 
means that the allelic subset involved in OA predisposition unlikely reaches significance in 155 
any single-Quantitative Trait Loci (QTL) analysis30. Genotyping of male F2 (STR/ort x 156 
C57BL/6) using 96 microsatellite markers and phenotyping by weight, serum COMP 157 
biomarker levels and knee OA revealed three weight-, one serum COMP- and one OA-158 
associated QTL on chromosome 830.  Backcrossing F1 STR/ort male to C57BL/6N females 159 
and linkage by microsatellite markers, again showed polygenicity with a QTL for OA instead 160 
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mapped to a 20 centimorgan region, proximal to chromosome 4’s centromere (another linked 161 
to OA onset in C57BL/6N mice on chromosome 5 was identified)31; together these data 162 
might simply support the existence of multiple murine OA loci. 163 
Revisiting chromosome 8 and fine mapping of the OA-QTL revealed Wnt-related genes 164 
associated with altered chondrogenesis, including dickkopf 4 (Dkk4), secreted frizzled related 165 
protein 1 (Sfrp1) and fibroblast growth factor 1 (Fgfr1), with 23 polymorphic changes in the 166 
Sfrp1 gene identified in STR/ort in comparison to C57BL/6 mice32, suggesting that reduced 167 
Sfrp1 expression not only increases Wnt/β-catenin signalling early in life but also renders the 168 
AC prone to premature OA32. This is similar to various genome-wide expression profiling 169 
studies in human OA which have also identified members of the Wnt/β-catenin signalling 170 
pathway as candidate genes associated with OA.33, 34 171 
Our recent studies also support an epigenetic contribution to STR/ort OA (unpublished). 172 
Careful joint OA scoring in individually-tracked male mice at 26wks of age found an 173 
important maternal influence, with a significant correlation between OA severity and 174 
maternal litter parity, and to a lesser extent with maternal age. Interestingly, no correlations 175 
were found with litter size nor with the time between litters, which suggests an important 176 
maternal influence during embryo development that underpins OA severity in STR/ort mice.   177 
Articular cartilage phenotype of STR/ort mice 178 
Matrix remodelling 179 
STR/ort mouse AC undergoes structural demise similar to human OA. Morphologically, 180 
STR/ort mouse AC is thicker than in CBA, and whilst STR/ort chondrocytes express a 181 
normal spectrum of PGs and collagens, there are early changes in AC matrix integrity and 182 
chondrocyte phenotype and function35-37. These include a subtle, yet progressive decay in PG 183 
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orientation prior to any decline in quantity, which was proposed to reflect the increased free 184 
water-content characteristic of human OA38. In addition, STR/ort mouse AC catabolic and 185 
anabolic gene expression profiles closely resembled those seen in other mouse OA models 186 
and in human OA11, consistent with increased MMP expression and activity37, 39, 40. The 187 
importance of MMPs in AC degradation in STR/ort mice has been tested by administration of 188 
Ro 32-3555, an orally active collagenase selective inhibitor which protected against OA 189 
development (Table 1)41. In addition, intra-articular injections of CRB0017 (anti-ADAMTS5 190 
antibody) dose-dependently slowed OA progression in STR/ort mice ageing from 5-8 months 191 
(Table 1)42. The likelihood that the STR/ort mouse model will help identify new preventative, 192 
protective and curative avenues targeting AC in OA joints is therefore well supported.  193 
Subtle changes in STR/ort AC matrix composition, and in glycosaminoglycan PG content in 194 
particular, is observed in STR/ort male mice in comparison to age-matched CBA mice36, 43. 195 
Indeed, chondroitin sulphate content, predominantly C6S, is elevated in STR/ort mice at 8 – 196 
19 weeks (before OA onset), decreases at 24-26weeks of age, before increasing again 197 
thereafter (after OA onset)36. These changes in AC composition may therefore impact AC 198 
function prior to OA onset and this highlights potential targets for therapeutic intervention. 199 
Chondrocyte phenotype  200 
Alternative approaches to redress the lack of therapeutics in OA are also now emerging. 201 
Evidence suggests that the normally ‘stable’ AC chondrocyte adopts a more ‘transient’ 202 
phenotype similar to growth plate chondrocytes in OA35, 44-46. This phenotype switching also 203 
occurs in STR/ort mice with the hypertophic marker Col10a1 mRNA significantly increasing 204 
in STR/ort AC compared to non-OA AC11, 35, 47. Consistent with this, Col10a1 205 
immunolabelling has been observed throughout AC of STR/ort mice before histological OA 206 
is detected35.  207 
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TUNEL-positive chondrocytes are observed around OA lesions in STR/ort AC, indicating 208 
apoptosis and chondrocyte transiency, correlating with OA progression48. The lack of any 209 
changes in the ratio of Bax:Bcl-2 in STR/ort AC48 indicates that this apoptosis is perhaps 210 
attributable instead to increased chondrocyte adenosine production49. Aberrant control of 211 
upstream regulators of apoptosis have also been found in STR/ort mouse AC; including 212 
prohibitin-1, a protein which restricts generation of reactive oxygen species, mitochondrial 213 
disorganization, abnormal cristae morphology and increased sensitivity towards stimuli-214 
elicited apoptosis50. In both STR/ort, and human AC, accumulation of prohibitin-1 along with 215 
Pitx1 repression was detected in OA chondrocyte nuclei, consistent with elevated apoptosis.  216 
It appears that STR/ort mouse AC chondrocytes also have an altered metabolic phenotype, 217 
with those in OA–prone regions having low lactate and succinate dehydrogenase activities 218 
prior to OA onset51, 52. This aberrant metabolic phenotype is also evident in lower glucose 6-219 
phosphate dehydrogenase activity and different monoamine oxidase localisation specifically 220 
in AC regions where OA develops53-55; the latter exhibiting potential for therapeutic targeting 221 
in STR/ort mice.  222 
Cell signalling pathways 223 
Discovery of the molecular determinants of OA in STR/ort mice will undoubtedly shed light 224 
upon OA aetiopathogenesis in other species and as such, have been well investigated. Our 225 
transcriptional profiling of STR/ort AC at various ages revealed differential regulation of 226 
many signalling pathways11, including an underexplored pathway relating to genes normally 227 
associated with the contractile machinery of muscle cells; expression of this gene subset is 228 
high in both young STR/ort and CBA mice, but remains high in OA STR/ort when a 229 
significant decrease is seen in healthy CBA aged samples11.  230 
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Major pathways such as those provoked by the transforming growth factor (TGF) β 231 
superfamily have already been investigated. Expression of TGF-β1 was indeed elevated 232 
during OA development in STR/ort compared to age-matched CBA mice56. Further, AC 233 
chondrocyte TGF-β3 and SMAD-2P protein expression decreased in STR/ort mice with 234 
advancing OA severity, except in areas of osteophyte formation where elevated levels 235 
persisted57; blocking studies suggest that TGF-β3 is involved in early and bone 236 
morphogenetic proteins (BMPs) in late osteophytogenesis57, 58. 237 
Effective regulation of the Wnt pathway is proving critical in OA joint pathology59  and 238 
levels of sFRP1, the Wnt inhibitor, are reduced in AC chondrocytes of young STR/ort mice32. 239 
We have reported a role for another Wnt inhibitor, sclerostin. This shows marked enrichment 240 
at the osteochondral interface in the relatively unaffected lateral tibia but its expression was 241 
severely disrupted in medial tibial regions showing AC loss and subchondral bone 242 
thickening35. Similar differential expression patterns of matrix extracellular 243 
phosphoglycoprotein (MEPE), an inhibitor of cartilage matrix mineralisation60 and 244 
downstream sclerostin target61, were also observed in STR/ort mice, implicating a novel 245 
mechanism by which sclerostin, and hence Wnt signalling functions in OA35, 59. Hypoxia 246 
inducible factor 1 (HIF-1α) also plays a major role in joint homeostasis and its inhibition 247 
rapidly provokes OA development in Balb/C mice. Intriguingly, HIF-1α stabilisation failed to 248 
prevent OA in STR/ort mice62 which further supports use of STR/ort mice in discerning 249 
whether identical pathological pathways are common to all forms of OA.  250 
Oxidative stress  251 
Oxidative stress has been shown to contribute to OA progression. In STR/ort mice, oxidative 252 
stress (malondialdehyde) and the collagen type II degradation (CTX-II) biomarker levels are 253 
both higher than in CBA mice prior to OA onset, suggesting that oxidative stress is linked to 254 
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AC type II collagen degradation63. Even before OA onset, young STR/ort mice show 255 
decreased levels of extracellular superoxide dismutase, the major scavenger of extracellular 256 
reactive oxygen species (ROS) in AC, and elevated nitrotyrosine formation at all ages, 257 
suggesting that inadequate control of ROS plays a pathophysiological role in OA64. This role 258 
is supported by markedly lower OA incidence in STR/1N mice following dietary 259 
supplementation (Table 1)65. More recently, apurinic/apyrimidinic endonuclease 2 (Apex 2) 260 
was also claimed to play a critical role in DNA repair caused by oxidative damage in STR/ort 261 
(STR/OrtCrlj) joints66.  262 
Bone phenotype of the STR/ort mouse 263 
Subchondral bone thickening (sclerosis) in OA joints, although often considered secondary, 264 
is nonetheless one of the earliest detectable changes and we have observed sclerosis in 265 
STR/ort joints with OA onset and development35. This agrees with decreased 266 
osteoclastogenesis (85Sr incorporation), increased bone apposition that is spatially associated 267 
with AC lesions in early STR/ort mouse OA (polychrome sequential bone labelling) and with 268 
early MRI in STR/ort mice where changes in patellar tendon and local sclerosis were 269 
identified67, 68. They are also consistent with a recent comprehensive multimodal micro-270 
computed tomography study which determined compartment-, age- and site-specific changes 271 
in subchondral bone in STR/ort mice evoking temporal changes that lead to an altered 272 
architecture contributing to their OA phenotype69. 273 
STR/ort mice also have a generalised high bone mass phenotype in cortical and trabecular 274 
compartments too (vs C57Bl/6), associated with elevated osteoblast numbers and activity, 275 
and impaired osteoclast function70. Indeed, changes in bone remodelling have already been 276 
implicated in the early stages of STR/ort mouse OA, where raised urinary CTX-II levels were 277 
apparent in an OA subgroup of STR/ort mice (vs non-OA subgroup71). Consistent with an 278 
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inherent bone phenotype, we have recently reported that young (6-week) STR/ort have 279 
increased cortical and trabecular parameters in comparison to age-matched CBA mice35. 280 
Surprisingly, this difference is noted significantly earlier and is more marked in female 281 
STR/ort mice, with an almost complete bone marrow compression and extramedullary 282 
haematopoiesis observed by 9 months70. This raises an interesting paradox regarding sexual 283 
dimorphism in this strain, where females show - on one hand - higher bone mass and 284 
protection from reproducible AC degeneration and where - on the other - male OA appears 285 
not to be influenced by hormone status37, 72. It therefore seems unlikely that high bone mass 286 
alone is sufficient to accelerate OA onset. Sexually dimorphic OA development might instead 287 
be due to architectural bone differences. Thus, early internal tibial torsion and lower 288 
cancellous bone mineral density evident in males may explain the differential incidence of 289 
OA in this STR/ort strain73.  290 
Clues to these changing osteochondral relationships in STR/ort mice might be evident in the 291 
endochondral ossification required for long bone growth. We recently observed accelerated 292 
growth dynamics in comparison to CBA mice with STR/ort mice exhibiting (i) an 293 
acceleration in body weight gain and tibia length at sexual maturity (ii) Col10a1 and MMP13 294 
expression widely dispersed into the growth plate proliferative zone (iii) differences in 295 
growth plate maturation zone sizes (iv) a dramatic acceleration of growth plate closure with 296 
bone bridge formation particularly clustered to medial areas where OA later predominates35. 297 
Together these studies suggest that STR/ort mice have an inherent endochondral ossification 298 
defect that drives their OA pathology. Interestingly, the relationship between longitudinal 299 
long bone growth rates and OA development in humans is a completely unexplored area. It is 300 
intriguing nonetheless that canine hip dysplasia, a hereditary predisposition to degenerative 301 
OA, is more common in certain breeds, in particular those larger breeds which tend to grow 302 
more rapidly74.  303 
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STR/ort mouse immune phenotype  304 
Although OA is not primarily a classic inflammatory disorder, it is accepted that cytokines 305 
play an important pathogenic role75. Indeed, Chambers et al (1997) found elevated IL-1β 306 
levels in AC chondrocytes of STR/ort mice at all ages56. In addition, serum levels of IL-1β, 307 
IL-4, IL-10, interferon γ were markedly higher in STR/ort mice76. Our previous microarray 308 
analysis in AC identified NFkB signalling as the main pathway modified in STR/ort mice (vs. 309 
CBA11) and  immunolabelling for the NFkB subunit p65 confirmed elevated levels in AC 310 
chondrocytes of STR/ort mice from 8 weeks of age11. The NFkB pathway is a recognised hub 311 
for inflammatory signalling which suggests links between chondrocyte cytokine production 312 
and signalling and catabolic changes in OA cartilage in STR/ort mice.  313 
Together these studies suggest that STR/ort OA has an important inflammatory component 314 
and this is further cemented by observations of spleen and lymph nodes abnormalities16. We 315 
more recently showed that male STR/ort mice possess significantly bigger spleens (with 316 
greater cellularity), decreased naïve T cell numbers, but increased activated T and B cell 317 
numbers, indicating a heightened inflammatory status11. This could perhaps be explained by 318 
the high bone mass phenotype of STR/ort mice (described above) and compression of the 319 
bone marrow necessitating extramedullary hematopoiesis70. Oxidative stress is associated 320 
with increased inflammatory mediator production and as such, reported increases in oxidative 321 
stress in STR/ort mice (see above) may provide an alternative explanation for these raised  322 
inflammatory markers levels63. These studies suggest a central function of inflammatory 323 
pathways to in STR/ort mouse OA development; they may also reflect a common molecular 324 
aetiology linking these OA and immune phenotypes.  325 
STR/ort mice exhibit increased AC expression of beta-defensins 3 and 4, broad-spectrum 326 
antimicrobial components of innate immunity. These findings offer a link between host 327 
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defence mechanisms and inflammation with AC tissue-remodelling processes77. Moreover, it 328 
is recognised that CGRP may contribute to human joint pain and CGRP/CGRP receptor 329 
signalling may indeed be modified in STR/ort mouse synovium via increased CD11c(+) 330 
macrophages, with high IL-1β in F4/80(+) and high CGRP, CLR, and RAMP1 in the F4/80(-) 331 
cell fraction, which can be ameliorated upon macrophage depletion, suggesting that synovial 332 
macrophages and IL-1β production may be suitable therapeutic targets for treating OA pain78. 333 
Obesity/metabolic syndrome in the STR/ort mouse  334 
Obesity is now a recognised OA risk factor and it has been reported that the parent STR/1N 335 
strain exhibits higher blood cholesterol and phospholipids compared to DBA/2JN and A/LN 336 
strains10. STR/ort mice have also been described as hypercholesterolemic and hyperlipidemic 337 
(raised cholesterol, high-density and low-density lipoprotein, triglyceride and insulin) without 338 
different glucose levels compared to C57Bl6/J and CBA/JN79. Regardless, it has been 339 
suggested that STR/ort mice should not be termed obese as their weight is significantly lower 340 
than ob/ob mice80. STR/ort mice also show low levels of serum adiponectin, a key player in 341 
glucose and lipid metabolism, which resembles human primary hypertriglyceridemic patients. 342 
Despite this, a reduction in body weight of STR/ort mice, using fenofibrate treatment, did not 343 
modify serum lipid composition nor OA severity81, suggesting that lipid metabolism 344 
anomalies were not the primary cause of spontaneous OA in STR/ort mice.  345 
More recently, microarrays on STR/ort AC/subchondral bone described upregulation of 331 346 
genes related to development and function of connective tissues, and 290 genes 347 
downregulated linked to lipid metabolism, in particular genes that were directly interacting 348 
with peroxisome proliferator-activated receptor (PPAR) alpha/PPARgamma82. While 349 
PPARalpha and PPARgamma mRNA levels themselves were not significantly altered, 350 
multiple PPAR pathway components were, leading the authors to conclude that decreased 351 
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PPAR signalling contributes to OA progression in STR/ort mice by promoting 352 
osteoblastogenesis and enhanced bone formation.  353 
Concluding remarks 354 
The STR/ort mouse is an excellent model of spontaneous osteoarthritis with disease 355 
pathology starting early in life and showing many similar characteristics akin to human 356 
primary OA. The phenotype of the STR/ort mouse is well characterised with pathology 357 
observed in the knee, elbow, ankle and temporomandibular joints of male mice; this 358 
highlights the sexual dimorphism in this strain, whereby females show higher bone mass and 359 
protection from reproducible AC degeneration. The highly defined and reproducible disease 360 
pathology of the STR/ort mouse has, to date, offered the unique opportunity to identify the 361 
pathological role that key determinants of the AC and subchondral bone phenotypes play in 362 
spontaneous OA development, highlighting the attractiveness of this murine model in 363 
exploring the aetiopathogenesis of spontaneous OA. Whether research in the OA field should 364 
focus upon pre-clinical studies or on clinical studies in man is still a matter of debate, and has 365 
been elegantly debated in a recent editorial by Hunter and Little1. However, with new 366 
acceptance that broad generalisation regarding OA aetiopathogenesis is somewhat distracting 367 
and flawed in our pursuit of a single disease‐modifying treatment, research in the OA field 368 
will undoubtedly look to utilise animal models such as the STR/ort mouse to yield greater 369 
understanding of primary OA. The recent research discussed herein certainly indicates that a 370 
better understanding of the genes, molecules and processes contributing to STR/ort mouse 371 
OA will aide significantly in the identification of new preventative, protective and curative 372 
avenues for OA.   373 
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 605 
Agent Action Outcome Ref. 
Naloxone Opiod 
antagonist 
No signs of pain-associated behaviours 20 
Ro 32-3555 
 
Collagenase 
inhibitor 
 
Reduction in joint space narrowing, osteophyte 
formation and protection against AC degradation 
and subchondral bone sclerosis 
41 
 
CRB0017 
 
anti-ADAMTS5 
antibody 
dose-dependently slowed OA progression in 
STR/ort mice ageing from 5-8 months 
42 
vitamins E, C, A, B6, 
B2, and selenium 
dietary 
supplementation 
Lower OA incidence 65 
